Evidence mapPaperPMID 41608539Full record

ReviewFrontiers in sports and active living2025

Challenging the principle of "No presumption of advantage" with a focus on testosterone and gender eligibility in sports.

Philip J Atherton, Ke Hu, Bernadette Jones-Freeman, Ada S Cheung, Ricardo J S Costa, Nir Eynon, Jane T Seto, Lukas Moesgaard, Morten Hostrup, Giscard Lima and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in sports and active living, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Philip J AthertonFaculty of Medicine & Health Sciences, Medical School, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom.
Ke HuDepartment of Sports and Health Sciences, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.
Bernadette Jones-FreemanAustralian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.
Ada S CheungTrans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, Melbourne, VIC, Australia.
Ricardo J S CostaDepartment of Nutrition Dietetics & Food, Monash University, Melbourne, VIC, Australia.
Nir EynonAustralian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.
Jane T SetoMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, VIC, Australia.
Lukas MoesgaardThe August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
Morten HostrupThe August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark.
Giscard LimaMurdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, VIC, Australia.
Yannis PitsiladisDepartment of Biology, Hong Kong Baptist University, Hong Kong, Hong Kong SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To evaluate the scientific validity of the International Olympic Committee's (IOC) 2021 framework principle of "No Presumption of Performance Advantage," which suggests that circulating testosterone levels alone does not confer a competitive advantage. Design: A critical review of existing scientific literature concerning the physiological effects of testosterone and male puberty on athletic performance, complemented by a forward-looking proposal for integrating multi-layered biological and performance data. Method: Relevant peer-reviewed studies were examined, focusing on the role of endogenous testosterone, the long-term effects of male puberty, and performance outcomes among transgender women and athletes with differences in sexual development (DSD). Emphasis was placed on strength, power, and endurance metrics. In addition, we outline the emerging potential of combining wearable sensor monitoring with omics profiling to generate a comprehensive, dynamic evidence base. Results: Evidence consistently shows that male puberty is associated with lasting increases in muscle mass, strength, speed, and endurance due to elevated testosterone. Current evidence also suggests such physiological adaptations may endure even after testosterone suppression, potentially mediated by muscle memory mechanisms such as myonuclei permeance and/or epigenetic changes. If verified, transgender women who experienced male puberty and later reduced testosterone levels retain physical advantages, particularly in strength-based sports. Similarly, athletes with DSD exhibiting male-range testosterone levels also show performance advantages in select events. Conclusions: The IOC's principle of "No Presumption of Performance Advantage" contradicts a substantial body of scientific evidence. While inclusion and fairness are important goals, the framework's rejection of testosterone as a key determinant of athletic performance risks undermining competitive fairness and athlete safety in sex-segregated sports, particularly where strength and power are critical. Acknowledging testosterone as a key determinant of performance, our study proposes a novel multi-layered evaluation framework that integrates real-time sensor data with omics analyses. This innovative approach supports the development of adaptive, context-specific, and ethically grounded policies that promote fair, inclusive, and safe competition while offering a forward-looking roadmap for future policy and research.

Indexed as

fairnessinclusionperformancesexual developmenttestosterone

Identifiers

PMID41608539
PMCPMC12835371

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.